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Available online 11 April 2017Background:WNT signaling plays amajor role in bone and cartilagemetabolism. ImpairedWNT/β-catenin signal-
ing leads to early-onset osteoporosis, but specific features in bone and other tissues remain inadequately charac-
terized.We have identified two large Finnish familieswith early-onset osteoporosis due to a heterozygousWNT1
mutation c.652TNG, p.C218G. This study evaluated the impact of impaired WNT/β-catenin signaling on spinal
structures.
Methods: Altogether 18 WNT1 mutation-positive (age range 11–76 years, median 49 years) and 14 mutation-
negative subjects (10–77 years, median 43 years) underwent magnetic resonance imaging (MRI) of the spine.
The images were reviewed for spinal alignment, vertebral compression fractures, intervertebral disc changes
and possible endplate deterioration. The findings were correlated with clinical data.
Results:Vertebral compression fractures were present in 78% (7/9) of those aged over 50 years butwere not seen
in youngermutation-positive subjects. All those with fractures had several severely compressed vertebrae. Alto-
gether spinal compression fractures were present in 39% of those with aWNT1mutation. Only 14% (2/14)muta-
tion-negative subjects had one mild compressed vertebra each. The mutation-positive subjects had a higher
mean spinal deformity index (4.0 ± 7.3 vs 0.0 ± 0.4) and more often increased thoracic kyphosis (Z-score N
+2.0 in 33% vs 0%). Further, they had more often Schmorl nodes (61% vs 36%), already in adolescence, and
their intervertebral discs were enlarged.
Conclusion: Compromised WNT signaling introduces severe and progressive changes to the spinal structures.
Schmorl nodes are prevalent even at an early age and increased thoracic kyphosis and compression fractures be-
come evident after the age of 50 years. Therapies targeting theWNT pathwaymay be an effective way to prevent
spinal pathology not only in those harboring a mutation but also in the general population with similar
pathology.







The importance ofWNT/β-catenin signaling for bonemass develop-
mentwas first discoveredwhenmutations in the co-receptor, low-den-
sity lipoprotein receptor-related protein 5 (LRP5)were identified as theetics, PO Box 63, University of
tie), tuukka.niinimaki@oulu.fi
camilla.schalin-jantti@hus.fi
, outi.makitie@helsinki.ficause for the osteoporosis-pseudoglioma syndrome [1–2]. Since then,
other skeletal disorders, including early-onset osteoporosis and various
high bonemass disorders such as van Buchem disease and sclerosteosis
due to either decreased or increased WNT signaling, respectively, have
further underlined this pathway's significance in bone homeostasis
[3–6]. Furthermore, several genome-wide association studies (GWAS)
have identified LRP5 and other components of theWNT signaling path-
way as major determinants of bone mass and fracture risk [7–8].
WNT signaling plays a major role in bone metabolism throughout
life—in skeletal development during embryonic phase, in bonemass ac-
crual during childhood and adolescence, and in maintenance of bone
homeostasis and renewal in adulthood [9]. In adult bone, the WNT
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chymal osteochondroprogenitor cells towards the osteoblastic lineage,
by promoting their proliferation and differentiation and by preventing
the apoptosis of uncommitted progenitor cells and mature osteoblasts
[10–11].WNT signaling also indirectly both stimulates and represses os-
teoclastogenesis through osteoblast-derived receptor activator of nucle-
ar factor-kappaB ligand (RANKL) and osteoprotegerin (OPG),
respectively [12–13]. Thesemechanisms have been elucidated in sever-
al genetically modified mouse models, in which impaired WNT signal-
ing leads to defects in bone formation and an osteoporotic phenotype
[14–15]. Concurrently, WNT signaling also mediates chondrogenesis,
sustains mature cartilage homeostasis in adults and, when improperly
activated, leads to cartilaginous tissue pathology [16–17].
WNT1 has been identified as a key ligand for the WNT/β-catenin
pathway in bone, as several loss-of-function mutations in WNT1 were
found to cause variable degrees of early-onset osteoporosis [15,18,19].
Apart from VCFs of the thoracic spine seen in plain radiographs [15], lit-
tle is known about the effects of defective WNT signaling in the axial
skeleton. Access to a unique research cohort with a large number of in-
dividualswithWNT1 osteoporosis prompted us to examine in detail the
consequences of impaired WNT signaling in the axial skeleton with
magnetic resonance imaging (MRI)—specifically, the prevalence and
characteristics of VCFs, the possible changes in vertebral endplates and
intervertebral discs, and the relationship of spinal changes with age.
Our findings on 18 mutation-positive subjects indicate that impaired
WNT signaling due tomutatedWNT1 causes significant and progressive
changes in the spine.
2. Subjects and methods
2.1. Subjects
During the course of our research program on early-onset osteopo-
rosis, we identified two large Finnish families with autosomal dominant
WNT1 osteoporosis. Initially, thefirst family included tenmutation-pos-
itive family members (Family A) [15]. All first-degree relatives at risk
were subsequently offered genetic screening for the family'sWNT1mu-
tation c.652TNG (p.C218G). Through genetic screening of an additional
21 family members, 10 other subjects were found to harbor the muta-
tion. The whole WNT1 gene was Sanger sequenced also for altogether
N250 other Finnish index subjects with early-onset osteoporosis and
another, seemingly unrelated family (Family B) was then found where
four out of eight subjects were positive for the same WNT1 mutation
as Family A. Thus altogether 24WNT1mutation-positive subjects were
identified in these two families, both of ethnic Finnish background. In
addition, 21 family members in these two families were confirmed by
genetic screening to be negative for the mutation.
We offered all mutation-positive subjects from Families A (n = 20)
and B (n = 4) an opportunity to participate in studies exploring the
skeletal and extra-skeletal consequences of the heterozygous WNT1
mutation, including MRI evaluation of the spine. In order to be able to
compare the findings with normal data, a control group with similar
age and sex distribution was formed by offering participation to WNT1
mutation-negative individuals in families A (n = 17) and B (n = 2),
aiming at similar age and sex distribution in the mutation-positive
and control groups. Altogether 18 mutation-positive and 14 mutation-
negative individuals consented. All subjects gave a written informed
consent upon participation in the study. The research protocol was ap-
proved by the Research Ethics Board of Helsinki University Hospital.
2.2. Genetic evaluations
Weperformed genetic validations onDNAextracted fromperipheral
blood, as described previously [20]. We screened all samples for the
families' known WNT1 heterozygous missense mutation c.652TNG(p.C218G) in exon 4 of the WNT1 gene (NCBI Reference Sequence
NM_005430.3).
2.3. Clinical cohort characteristics
Mutation-positive subjects were clinically evaluated at Helsinki Uni-
versity Hospital for clinical features, including anthropometry, align-
ment and abnormalities of spine. For all subjects, data on sustained
fractures and previous medical and surgical treatments were collected
by interview and frommedical records. History of back painwas record-
ed by interview; pain that required long-termmedication, absence from
work or professional help (e.g. physiotherapy) was considered dis-
abling. All secondary causes of skeletal fragility (e.g. long-term illness
or glucocorticoid treatment, low vitamin D status, or other biochemical
or endocrine abnormality) had been ruled out previously [15,20].
2.4. Magnetic resonance imaging
Magnetic resonance imaging (MRI) of the thoracic and lumbar spine
were performed in 2015–2016 at the Oulu University Hospital with a
1.5-T scanner (MAGNETOM Aera; Siemens Healthcare, Erlangen, Ger-
many) using a 32-channel spine coil. The imaging sequences included
T1-weighted turbo inversion recovery magnitude (TIRM) sagittal
images (TR/TE/TI 1900/10/860 ms, FOV 280 × 280 mm, matrix
320 × 240 pixels, slice thickness 4 mm, and 0.8 mm interslice gap)
and T2-weighted turbo spin echo (TSE) sagittal images (TR/TE 4000/
99 ms, FOV 280 × 280 mm, matrix 448 × 358 pixels, slice thickness
4 mm, and 0.8 mm interslice gap) of lumbar spine and T2-weighted
TSE sagittal images (TR/TE 3500/97 ms, FOV 280 × 280 mm, matrix
384 × 269 pixels, slice thickness 4 mm, and 0.8 mm interslice gap) of
thoracic spine. All images were obtained in supine position with the
subject lying down, legs extended horizontally.
TheMRIswere first independently assessed for spinal changes by an
orthopedic surgeon and an experienced radiologist who were blinded
to the subjects' genotype and phenotype. The final conclusions were
evaluated for discrepancy by calculating Intraclass Correlation Coeffi-
cient (ICC) for 10 randomly selected cases; for all the cases the ICC
scorewas N0.80 and therefore the analyseswere considered highly con-
sistent and reproducible. TheMRI data were assessed as described later.
2.4.1. Vertebrae and intervertebral discs
Changeswere evaluated separately for each vertebral body. Thoracic
and lumbar vertebrae were first classified according to the Genant et al.
semi-quantitativemethod by grading each vertebral body andVCF from
T4 to L4 as 0) normal; 1)mild (decrease in height 20–25%); 2)moderate
(decrease in height 25–40%); or 3) severe (decrease in height N 40%)
[21]. The extent of vertebral changes was further evaluated using the
spinal deformity index (SDI; scale 0–39) described by Minne et al.
[22]. The SDI classification integrates number and severity of VCFs by
summing all compression fracture scores. This classification has been
proven accurate in assessing VCFs in osteoporotic patients [23].
2.4.2. Endplates
The number, location and extent of Schmorl nodes (SN) were re-
corded by using modified classification introduced by Samartzis et al.
[24] The recorded domains were: vertebrae level (T4–L4), endplate in-
volvement (rostral, caudal, or both) and size (b1/3, b2/3, or N2/3
endplate). The vertebrae having moderate or severe VCF (SDI N1)
were not included in assessment.
2.4.3. Spinal alignment
Changes in spinal curvature were evaluated by calculating degrees
for thoracic kyphosis and lumbar lordosis. Values were measured by
selecting upper and lower vertebral bodies: T1 and T12 for thoracic
spine, and L1 and L5 for lumbar spine. The angle was calculated using
a modified Cobb's method by drawing tangent lines to these vertebral
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two groups [25]. Measured values were also transformed into Z-scores
based on age and sex-specific normative data according to Fon et al.
[26].
2.4.4. Statistical analysis
Descriptive data are reported asmedian and range or asmean± SD.
Normality of the data was assessed using Kolmogorov-Smirnov and
Shapiro-Wilk and visually using histograms. Unpaired 2-tailed Student
t- and Mann-Whitney U test were used as appropriate (SPSS Statistics





The 18 WNT1 mutation-positive subjects (13 females, 5 males)
ranged in age from 11 to 76 years (median 49 years) (Fig. 1, Table 1). Al-
together 16 (89%) of them had sustained at least one previous fracture.
Twelve subjects (67%) reported back pain; six of them considered the
pain disabling. Five adults reported height loss of ≥4 cm. None of the
subjects reported high-impact trauma that would have caused spinal
fractures. Nine subjects had received osteoporosis medication before
the diagnosis of WNT1 osteoporosis and prior to the study and for
three subjects, the treatment was still ongoing (Table 1).
3.1.2. Mutation-negative subjects
The 14 WNT1 mutation-negative subjects (7 females and males)
ranged in age from 10 to 77 years (median 43 years) (Fig. 1, Table 1). Al-
together 3 (21%) of themhad sustained oneormore previous peripheral
fractures, none had been diagnosed with compression fractures, three
had mild back pain and one adult reported a 4 cm height loss. None
had received any osteoporosis medications.
3.2. MRI findings
3.2.1. Vertebrae
VCFs were frequent and increasingly prevalent with age in the mu-
tation-positive subjects; none of the subjects younger than 50 years
had VCFs but seven out of nine (78%) of those over 50 years hadFig. 1. Pedigrees of the two Finnish families with a heterozygous p.C218G Wmultiple VFCs ranging from mild to severe (Fig. 2A). In comparison,
two out of the five mutation-negative subjects over the age of
50 years had a VCF, only one Genant grade 1 fracture each. The mean
SDI-score for the mutation-positive subjects was 4 ± 7.3 and for the
mutation-negative subjects 0 ± 0.4 (p = 0.07) (Figs. 2 and 3A–C). In
themutation-positive subjects, VCFsweremore prevalent in the thorac-
ic spine and either mild (Genant grade 1) or severe (Genant grade 3)
while moderate changes (Genant grade 2) were present mainly in the
lumbar spine.
3.2.2. Vertebral endplates
In twomutation-positive subjects, severe VCFs prevented the evalu-
ation of SNs. Eleven (69%) of the remaining 16 mutation-positive sub-
jects had SN. In all of them SNs were present in the thoracic vertebrae
and in six subjects, also in the lumbar spine (Figs. 3A and 4). Median
number of SN in the mutation-positive subjects was 3 (range 0–16). In
all these 11 subjects, the SNs were multilevel (i.e. seen in more than
one endplate), present in all vertebral endplates, predominantly situat-
ed in T7 to L1 andmost common in T9 (15%). Altogether 57% of the SNs
were rostral, 63% involved one third of an endplate, and none involved
more than two thirds of an endplate. In mutation-negative subjects the
SNswere less prevalent (p=0.07) as 5 (36%) of the 14 subjects had SN;
four in the thoracic spine, one in the lumbar spine and one subject in
both.Mediannumber of SNwas 0 (range 0–3). Theyweremostly rostral
(64%), most common in T11 (36%) and mostly (64%) one third of an
endplate in size.
3.2.3. Intervertebral discs
Intervertebral discs in the lumbar spine appeared enlarged in the
mutation-positive group (Fig. 3D). Median surface area of the interver-
tebral discs from L3 to L5 tended to be greater in the mutation-positive
than in the mutation-negative subjects but this difference was not sta-
tistically significant (962 vs 844mm2, p=0.24). Enlarged discswere bi-
concave in shape (“fish” or “hourglass vertebrae”). No enlarged discs
were observed in the thoracic spine.
3.2.4. Spinal alignment
VCFs caused changes in the WNT1 subjects' spinal alignment. Tho-
racic kyphosis was significantly increased in the mutation-positive sub-
jects and the median value for kyphosis was 39° (vs 34°, p = 0.01). The
median values of kyphosis for themutation-positive andmutation-neg-
ative subjects under the age of 50 yearswere 36° in both (p=0.49), andNT1 mutation. The pedigrees have been modified to ensure anonymity.
Table 1
History of fractures and previous osteoporosis medication for 18 subjects with a heterozygous p.C218GWNT1mutation and 14 mutation-negative subjects. ALE, alendronate; ZOL, zole-
dronic acid; BP, bisphosphonate; O, denosumab; N/A, data not available; VCF, vertebral compression fracture.
Subject Age (years) Sex (M/F) Osteoporosis medication
Peripheral fractures
History of VCF Back pain Height loss (cm)
Number Age at 1st fracture (years)
Mutation-positive subjects
AIV-6 11 F None 1 0 − − 0
AIV-5 13 M None 4 N/A − − 0
AIV-8 13 F None 1 8 − − 0
AIV-4 17 F None 8 0 − − 0
AIV-7 19 M None 1 12 − − 0
BIII-2 31 F ALE 2008–2013 11 0.6 − + 0
AIII-2 34 F None 2 N/A − − 0
AIII-12 44 F None 0 − − + 0
AIII-7 48 F ZOL 2010– 4 N/A − + 0
BII-1 51 F BP (name N/A) 2002–2007 2 35 − + N/A
AIII-14 52 F None 0 − − + N/A
AIII-3 52 M N/A 2 10 + + 0
AIII-5 53 F RIS 2001–2003
PTH 2012–2013
0 − + + 4
AII-1 63 M ZOL 2007–2010
PTH 2011–2013
3 18 + + 7
BII-2 68 F ALE 2007–2014 5 N/A − + 2
AII-2 72 F Estrogen (name N/A)
RIS 2006–
9 7 + + 13




6 42 + + 17
AII-4 76 M ZOL 2008
PTH 2011–2012
1 N/A + + 4
Mutation-negative subjects
AIV-1 10 M None 0 – − − 0
AIV-2 16 M None 0 – − − 0
AIV-10 18 F None 0 – − − 0
AIV-8 21 F None 0 – − − 0
AIV-9 27 F None 0 – − − 0
AIII-1 37 F None 0 – − − 0
AIII-5 42 M None 0 – − − 0
BIII-3 43 M None 0 – − − 0
AIII-12 49 F None 0 – − − 0
AIII-7 53 M None 0 – − − 0
AIII-10 56 F None 5 19 − + 4
AIII-9 57 F None 0 – − − 0
AIII-8 59 M None 5 23 − +/− 0
BII-2 77 M None 1 48 − + 0
Fig. 2. A) Spinal deformity index (SDI) and B) kyphosis Z-scores in 18WNT1 p.C218G mutation-positive and 14 mutation-negative subjects.
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Fig. 3. Spinal magnetic resonance images of four WNT1 p.C218G mutation-positive subjects. A) Thoracic spine of a 17-year-old female showing multiple Schmorl nodes (arrow). B)
Thoracic spine of a 44-year-old female showing exaggerated thoracic kyphosis. C) Thoracic spine of a 76-year-old male showing several compressed vertebrae (arrow), kyphotic
stature and Schmorl hernia (dashed arrow). D) Lumbar spine of a 74-year-old female showing several compressed vertebrae and enlarged intervertebral discs (arrow).
7R.E. Mäkitie et al. / Bone 101 (2017) 3–9for subjects over the age of 50 years 57° and 31° (p= 0.01), respective-
ly.When the degree of kyphosis was comparedwith published age- and
sex-specific normative data, therewas a significant difference in kypho-
sis Z-scores between the mutation-positive and -negative subjects
(Fig. 2B), especially after age 50 years. Thoracic kyphosis was signifi-
cantly (p = 0.02) increased in the mutation-positive subjects; 6 out of
18 mutation-positive subjects had a kyphosis Z-score N +2.0 while all
mutation-negative subjects had a Z-score within the −1.5 to +1.5
range. There was also an increase in kyphosis with increasing age
(Fig. 3A–C). The median values for lumbar lordosis were 41° and 44°
in the mutation-positive and -negative subjects, respectively (p =
0.47); for subjects under the age of 50 years the values were 35° and
40° (p = 0.40) and for those over the age of 50 years, 48° and 54° (p =
0.32), respectively.Fig. 4. Number of Schmorl nodes and unassessable vertebrae (SDI N 1) in 184. Discussion
This study reports for the first time a systematic evaluation of the
spine by MRI in a large cohort of patients with an inherited defect in
WNT signaling. We assessed the spine in 18 mutation-positive subjects
in two families with autosomal dominantWNT1 osteoporosis and in 14
mutation-negative relatives from the same two families. We previously
showed that this WNT1 missense mutation p.C218G impairs WNT sig-
naling [15] and that affected individuals have increased peripheral frac-
tures and compromised bonemass accrual in childhood and early-onset
osteoporosis in adulthood [20]. Findings of the present study, involving
pediatric and adult subjects, suggest that the negative effects of im-
pairedWNT signaling on the spine accumulate with age and lead to sig-
nificant spinal pathology by mid adulthood. Comprehensive evaluationWNT1 p.C218G mutation-positive and 14 mutation-negative subjects.
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discs, by MRI showed that all these spinal structures are affected.
VCFs were common and caused significantly increased kyphosis in
mutation-positive adults. All subjects with fractures were older than
50 years, fracture prevalence being 78% in that age group. Fractures
were also more severe and involved more vertebrae than in the muta-
tion-negative subjects (mean SDI 4 ± 7.3 vs 0 ± 0.4). Further, the
WNT1mutation-positive subjects hadmore often increased thoracic ky-
phosis (33% vs 0%) and SNs (61% vs 36%) than the mutation-negative
subjects.
Thewide age distribution in our cohort enabled us tomake some ob-
servations about the vertebral changes' relationship to age. We have
previously shown that some skeletal changes are already seen in early
childhood and that adults present with severe early-onset osteoporosis
[4,18]. The present study showed phenotypic variability among subjects
with same age. Most of the spinal changes occurred only past the age of
50 years, when a notable increase in pathological findings was seen in
both males and females. Similarly, functionally significant LRP5 poly-
morphisms modulate bone mass accrual during childhood and lead to
subnormal lumbar spine BMD by adulthood [3,27,28]. In 10 individuals
with defective WNT signaling due to a heterozygous LRP5mutation we
showed that the magnitude of BMD deterioration and presence of VCFs
associated with the patient's age. It seems likely that the changes in the
axial spine accumulate during childhood and young adulthood and
when a certain threshold BMD is reached, spinal changes (i.e. compres-
sion fractures and kyphosis) occur.
WNT signaling is also of key importance in cartilaginous tissues.
WNTs function as a molecular switch in determining mesenchymal
stem cells' commitment to either osteoblastic or chondrogenic lineage,
and orchestrate their sequential proliferation and differentiation [29].
In the present study, spinal cartilaginous tissue was studied by evaluat-
ing defects in spinal endplates and intervertebral discs. SNs were twice
as common in the mutation-positive subjects (69% vs 36%), were pres-
ent at all ages and were atypically more frequent in the thoracic spine.
They were also more common at an earlier age (one subject had 10
SNs at 17 years). SNs are intravertebral disc herniations often associated
with disc degeneration and weakened vertebral bone, and usually seen
near the thoracolumbar junction [30]. While our results suggest low
BMD to be a risk factor for SNs, the WNT1 mutation may also hamper
normal formation of cartilage,making the endplatesmore prone to her-
niation. As the SNsweremore frequent and had earlier onset in themu-
tation-positive subjects, the presence of SN may be predictive of future
VCFs. This however needs to be evaluated in a longitudinal study. Fur-
ther, the overall role ofWNT signaling in cartilage needs to be addressed
in future studies.
Our study has some limitations, mainly concerning the relatively
small cohort size and the cross-sectional nature of the study. Also,
some of themutation-positive subjects had received osteoporosis treat-
ment prior to the study, influencing the natural course and improving
the skeletal pathology. Importantly however, the presence of significant
spinal pathology despite several years' medical treatment suggests that
the available treatment modalities are not optimal. We did not use val-
idated methods to evaluate the degree and actual cause of back pain,
and physical and quality-of-life consequences of spinal changes; these
would be important to gain more understanding of the disease burden.
The MRI images were taken in supine position and compared against
data taken in standing position. Several studies have indicated that ky-
phosis is decreased in supine versus standing position [31] and hence
our study may have underestimated the degree of kyphosis. Lastly, as
our study focuses solely on the spine, no other parts of the skeleton
(e.g. knee or hip joints) were included. Evaluation of the appendicular
skeleton in future studies will provide more comprehensive under-
standing of the skeletal and cartilaginous effects of theWNT1mutation.
Despite these limitations, our study provides new and important infor-
mation regarding the clinical implications of impairedWNTsignaling on
the spine. This is the largest reported genetically homogeneous cohortof subjectswith amutation in theWNT signaling pathway. Thepresence
of an identical mutation in all affected subjects of all ages, and inclusion
of mutation-negative subjects from only two families allowed us to
make several observations regarding the spinal changes' relationship
to aging.
We conclude that defective WNT signaling due to the WNT1 muta-
tion p.C218G causes significant changes in the spine that are present
both in bony vertebrae and in cartilaginous tissues, are evident in al-
most all subjects over the age of 50 years and become increasingly se-
vere with age. VCFs and exaggerated kyphosis are a clinically
significant and commonproblem, causing pain, physical limitations, im-
paired quality of life and increased morbidity [32]. Whether these
changes are apparent in other tissues of the appendicular skeleton is
left unexplored andwill be subject to future studies. Therapies targeting
theWNT pathwaymay be an effective way to prevent spinal pathology
not only in those harboring a mutation but also in the general popula-
tion with similar pathology.
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